Technical analysis of Compugen Ltd. (CGEN): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Compugen Ltd., an Israeli-based company established in 1993 and headquartered in Holon, is a clinical-stage enterprise focused on the discovery, development, and commercialization of therapeutic and product candidates. Its operations extend across Israel, the United States, and Europe.
Price Performance
| 1 month | +1.26% |
| 3 months | +19.90% |
| Year-to-date | +57.52% |
| 1 year | +77.21% |
| 3 years | +129.52% |
| 5 years | -64.08% |
52-Week Range
| 52-week High | $3.24 |
| 52-week Low | $1.30 |
| Avg Volume (90d) | 356K |
Technical Indicators
| SMA 50 | $2.45 |
| SMA 200 | $2.20 |
| Beta | 2.77 |
| 30-day Volatility (annualised) | 54.7% |
| Price vs SMA 50 | -1.6% |
| Price vs SMA 200 | +9.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.77 | |
| 2025-11 | $1.56 | -11.9% |
| 2025-12 | $1.53 | -1.9% |
| 2026-01 | $1.84 | +20.3% |
| 2026-02 | $1.81 | -1.6% |
| 2026-03 | $2.13 | +17.7% |
| 2026-04 | $2.66 | +24.9% |
| 2026-05 | $2.63 | -1.1% |
| 2026-06 | $2.14 | -18.6% |
| 2026-07 | $2.35 | +9.8% |
| 2026-08 | $2.56 | +8.9% |
| 2026-09 | $2.41 | -5.9% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | |
| 2026-09-15 | $-0.02 | |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | | |
Price
| Price | $2.41 |
| Market Cap | $228M |
| Exchange | NASDAQ |
| Country | IL |
Valuation Ratios
| P/E Ratio | 6.42 |
| Price / Book | 2.57 |
| EV / EBITDA | 6.74 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.03 |
| Current Ratio | 5.72 |
| Piotroski F-Score | 6 |
| Altman Z-Score | -0.38 |